- Home
- DC vs IART Comparison
DC vs IART Comparison
Compare DC & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DC | IART |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | 41 | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.8M | 731.1M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | DC | IART |
|---|---|---|
| Price | $5.22 | $9.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 7 |
| Target Price | $9.48 | ★ $14.50 |
| AVG Volume (30 Days) | ★ 1.7M | 741.8K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.40 | $8.70 |
| 52 Week High | $7.25 | $20.55 |
Technical Indicators
Market Signals| Indicator | DC | IART |
|---|---|---|
| Relative Strength Index (RSI) | 47.95 | 44.85 |
| Support Level | $4.38 | $8.70 |
| Resistance Level | $5.51 | $9.91 |
| Average True Range (ATR) | 0.32 | 0.45 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 61.09 | 68.65 |
Price Performance
Historical ComparisonAbout DC Dakota Gold Corp.
Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine. Company project includes Richmond Hill Project.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.